Keisuke Kiyota
- Gastroenterology top 2%
- Gastroesophageal reflux and treatments 6
- Gastrointestinal Tumor Research and Treatment 3
- Gastrointestinal motility and disorders 2
-
- Helicobacter pylori-related gastroenterology studies 9
- Eosinophilic Esophagitis 6
-
- Metastasis and carcinoma case studies 4
- Gastric Cancer Management and Outcomes 4
-
- Veterinary medicine and infectious diseases 3
Keisuke Kiyota
21 papers receiving 387 citations
Peers
Comparison fields: 5 of 73
- Gastroenterology 181
- Surgery 271
- Pulmonary and Respiratory Medicine 142
- Small Animals 23
- Leadership and Management 2
Countries citing papers authored by Keisuke Kiyota
This map shows the geographic impact of Keisuke Kiyota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Kiyota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Kiyota more than expected).
Fields of papers citing papers by Keisuke Kiyota
This network shows the impact of papers produced by Keisuke Kiyota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Kiyota. The network helps show where Keisuke Kiyota may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keisuke Kiyota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 11 | |
| 2 | [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis responding remarkably to combination chemotherapy of docetaxel, CDDP and S-1]. | 2008 | 1 |
| 3 | 2003 | 64 | |
| 4 | 2001 | 2 | |
| 5 | 2000 | 1 | |
| 6 | [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist]. | 2000 | 2 |
| 7 | [The clinical evaluation of structured questionnaire for reflux esophagitis]. | 2000 | 4 |
| 8 | Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial. | 1999 | 9 |
| 9 | A Validation of the Hospital Anxiety and Depression Scale. | 1998 | 85 |
| 10 | 1998 | 11 | |
| 11 | 1998 | 5 | |
| 12 | 1996 | 56 | |
| 13 | [Measurement of gastric emptying by magnetic resonance imaging]. | 1996 | 2 |
| 14 | 1989 | 97 | |
| 15 | 1988 | 1 | |
| 16 | 1987 | 22 | |
| 17 | 1986 | 5 | |
| 18 | 1986 | 2 | |
| 19 | 1985 | 2 | |
| 20 | [Clinical evaluation of endoscopic retrograde biliary drainage (ERBD) in comparison with that of precutaneous transhepatic biliary drainage (PTBD)]. | 1985 | 0 |
About Keisuke Kiyota
Keisuke Kiyota is a scholar working on Gastroenterology, Small Animals and Surgery, having authored 22 papers that have together received 398 indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (9 papers), Gastroesophageal reflux and treatments (6 papers), Eosinophilic Esophagitis (6 papers), Metastasis and carcinoma case studies (4 papers), Gastric Cancer Management and Outcomes (4 papers), Veterinary medicine and infectious diseases (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers) and Gastrointestinal motility and disorders (2 papers). The work is most often cited by research in Gastroenterology (181 citations), Surgery (271 citations) and Pulmonary and Respiratory Medicine (142 citations). Keisuke Kiyota has collaborated with scholars based in Japan, Germany and Greece. Frequent co-authors include Masanobu Nakajima, Kazuya Kawai, Kenjiro Yasuda, Shigeto Yoshida, Hideto Inokuchi, Yasuki Habu, Keiichi Kawai, Kiyohiko Kawai, Hiroyuki Hatta and Shigeto Mizuno. Their work appears in journals such as Gastroenterology, Gastrointestinal Endoscopy and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.